Bill 119 HR 2511, also known as the Caffeine Labeling Act, aims to amend the Federal Food, Drug, and Cosmetic Act to introduce specific labeling requirements for products containing caffeine. The bill seeks to address concerns about the potential health risks associated with consuming high levels of caffeine, particularly among young people.
Under this proposed legislation, manufacturers of food and beverage products that contain caffeine would be required to clearly label the amount of caffeine present in their products. This information would need to be prominently displayed on the packaging to ensure that consumers are fully informed about the caffeine content of the products they are purchasing.
The Caffeine Labeling Act is designed to empower consumers to make more informed choices about their caffeine consumption and to help prevent potential health issues related to excessive caffeine intake. By providing clear and accurate information about the caffeine content of products, this bill aims to promote public health and safety.
Overall, the Caffeine Labeling Act represents a proactive approach to addressing the growing concerns surrounding caffeine consumption and its potential impact on public health. If passed, this legislation would require manufacturers to be transparent about the caffeine content of their products, ultimately benefiting consumers and promoting greater awareness of the potential risks associated with excessive caffeine consumption.